Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | 182,774 | reported | 02 Apr 2025 | tx 7+603,000−21,226 |
| Engility Holdings, Inc. | 0 | reported | 14 Jan 2019 | tx 1−8,960,446 |
| Frazier Lifesciences Acquisition Corp | 0 | reported | 22 Nov 2022 | tx 1−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Apr 2025 | SALE | Arcutis Biotherapeutics, Inc. | 9,600 | 15.80 USD | |
| 28 Feb 2025 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 34,000 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 89,000 | 0.00 USD | deriv |
| 24 Sept 2024 | SALE | Arcutis Biotherapeutics, Inc. | 11,626 | 9.48 USD | |
| 21 Sept 2024 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 60,000 | 0.00 USD | |
| 10 Apr 2024 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 110,000 | 0.00 USD | |
| 10 Apr 2024 | GRANT_AWARD | Arcutis Biotherapeutics, Inc. | 310,000 | 0.00 USD | deriv |
| 22 Nov 2022 | EXERCISE | Frazier Lifesciences Acquisition Corp | 30,000 | — | deriv |
| 14 Jan 2019 | OTHER | Engility Holdings, Inc. | 8,960,446 | — |